New Griffith University research has found that sugars decorating human cells allow toxins, produced by disease-causing bacteria, to bind to human cells and cause damage or death. The family of toxins known as cholesterol-dependent cytolysins (CDCs), are produced by bacteria such as Streptococcus pneumoniae, group A Streptococcus and Listeria monocytogenes, which cause pneumonia, invasive group […]
Strep A, which can lead to serious illness and death if untreated, should be recognised as a Neglected Tropical Disease according to a leading infectious disease expert. Professor Michael Good AO, Principal Research Leader at Griffith University’s Institute for Glycomics, authored a paper published this week in PLOS Neglected Tropical Diseases. Neglected tropical diseases (NTDs) […]
The Institute for Glycomics has been awarded two National Health and Medical Research Council Investigator Grants.
Philanthropy has helped accelerate research into streptococcus leading scientists to exciting new discoveries in stroke and toxic shock prevention and treatments.
Lives are at risk due to ceasing research on diseases that in addition to COVID-19 have a major impact on public health warn scientists.
Researchers from the Institute for Glycomics and the University of Adelaide, have entered into an exclusive licensing deal with Sienna Cancer Diagnostics Ltd to commercialise a novel cancer diagnostic tool. Together, the teams of researchers have engineered a unique protein, called SubB2M, that binds specifically to a sugar molecule only present in cancer cells – a potential […]
Four teams of expert scientists from Griffith University’s Institute for Glycomics are targeting the virus SARS-CoV-2 to discover new vaccines and drugs to prevent or cure COVID-19. The teams are led by the Institute’s group leaders Professor Mark von Itzstein AO, Professor Michael Good AO, Professor Michael Jennings, and Professor Johnson Mak, all world-renowned research […]